CDH1 and breast cancer: First, we compared the expression levels of all oncomirs that can target E-cadherin ORF in breast cancer tissues or metastatic MDA-MB-231 cells with those in distal non-tumor tissues or non-metastatic MCF-7 cells, respectively.